Yayınlar & Eserler

Yayın Ağı
Makaleler 50
Tümü (50)
SCI-E, SSCI, AHCI (41)
SCI-E, SSCI, AHCI, ESCI (43)
ESCI (2)
Scopus (45)
TRDizin (6)
Diğer Yayınlar (4)

1. Targeting SIRT2 with Oxadiazole/Thiadiazole-Based Acetamides: In Silico Screening and In Vitro Cytotoxicity Evaluation

Aksel A. B., GÖZELLE M., BAKAR ATEŞ F., ÖZKAN Y., Ozkan E., EREN G.
POLYCYCLIC AROMATIC COMPOUNDS , 2025 (SCI-Expanded) identifier

2. In silico approach reveals N-(5-phenoxythiophen-2-yl)-2-(arylthio)acetamides as promising selective SIRT2 inhibitors: the case of structural optimization of virtual screening-derived hits

GÖZELLE M., BAKAR ATEŞ F., Massarotti A., Ozkan E., Gunindi H. B., ÖZKAN Y., et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , cilt.43, sa.4, ss.1756-1767, 2025 (SCI-Expanded) identifier identifier identifier

3. 2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition

Kaya S. G., Eren G., Massarotti A., Bakar-Ates F., Ozkan E., Gozelle M., et al.
DRUG DEVELOPMENT RESEARCH , cilt.85, sa.4, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

4. Linker and tail group modifications on 2-((4-isopropyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-phenoxyphenyl)acetamide to improve SIRT2 inhibitory potency

GÖZELLE M., ÖZKAN Y., EREN G.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.49, sa.2, ss.317-332, 2024 (Scopus)

5. Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity

Gözelle M., Kaya S. G., Aksel A. B., Özkan E., Bakar Ateş F., Özkan Y., et al.
Bioorganic Chemistry , cilt.123, ss.105746, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

6. Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study

OLĞAÇ S., OLĞAÇ A., YENİCESU İ., ÖZKAN Y.
BIOORGANIC CHEMISTRY , cilt.121, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

7. Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis

Menekse E., Aydin S., Aydin O. U., Sahin D., Akca G., Eroglu A., et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.68, sa.3, ss.362-366, 2022 (SCI-Expanded) identifier identifier identifier

8. The potential of 4-aryl-6-morpholino-3(2H)-pyridazinone-2-arylpiperazinylacetamide as a new scaffold for SIRT2 inhibition: in silico approach guided by pharmacophore mapping and molecular docking

ŞÜKÜROĞLU M. K., GÖZELLE M., ÖZKAN Y., EREN G.
MEDICINAL CHEMISTRY RESEARCH , cilt.30, sa.10, ss.1915-1924, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

9. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT

Yagci S., Gözelle M., Kaya S. G., Özkan Y., Aksel A. B., Bakar-Ates F., et al.
BIOORGANIC & MEDICINAL CHEMISTRY , cilt.30, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

10. Homocysteine thiolactonase activity in coronary atherosclerosis

Altinay A., Kısa Ü., Tulmac M., Özkan Y.
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.11, sa.6, ss.634-638, 2020 (ESCI) identifier

11. Determination of Tryptophan and Kynurenine by LC-MS/MS by Using Amlodipine as an Internal Standard

Eser B., ÖZKAN Y., SEPİCİ DİNÇEL A.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY , cilt.31, sa.2, ss.379-385, 2020 (SCI-Expanded) identifier identifier identifier

12. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening

Ozgencil F., EREN G., ÖZKAN Y., GÜNTEKİN ERGÜN S., ATALAY R.
BIOORGANIC & MEDICINAL CHEMISTRY , cilt.28, sa.1, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. Microwave-assisted synthesis and pharmacological screening of some triazolothiadiazole derivatives

Gorgu O., YILDIRIM E., ÖZKAN Y., Cakir B., Erol K., ÖNKOL T.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.56, 2020 (SCI-Expanded) Creative Commons License identifier identifier

14. Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors

Eren G., Bruno A., Guntekin-Ergun S., Atalay R., Ozgencil F., Özkan Y., et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING , cilt.89, ss.60-73, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents

Inceler N., ÖZKAN Y., Turan N. N., KAHRAMAN D. C., ATALAY R., BAYTAŞ S.
MEDCHEMCOMM , cilt.9, sa.5, ss.795-811, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

16. Neopterin: A possible biomarker in gastrointestinal cancer

HACIŞEVKİ A., Baba B., Aslan S., ÖZKAN Y.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.42, sa.2, ss.32-41, 2018 (Scopus) Sürdürülebilir Kalkınma identifier

17. Neopterin: A possible biomarkers in gastrointestinal cancer

HACIŞEVKİ A., BABA B., aslan s., ÖZKAN Y.
Journal of Faculty of Pharmacy ankara , cilt.42, sa.2, ss.32-41, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

18. Evaluation of Tryptophan/Kynurenine Pathway Relevance With Immune System Biomarkers of Low Energy Trauma Hip Fractures in Osteoporotic Patients

Dincel E., Özkan Y., Sukuroglu M. K., Ozsoy H., Sepici Dinçel A.
ARCHIVES OF RHEUMATOLOGY , cilt.32, sa.3, ss.203-208, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

19. Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives

YURTTAŞ L., Abu Mohsen U., ÖZKAN Y., Cobanoglu S., LEVENT S., KAPLANCIKLI Z. A.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.31, sa.6, ss.1177-1183, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

20. Association of obstructive sleep apnea with homocystein Nitric oxide and total antioxidant capacity levels in patients with or without coronary artery disease

ORTAÇ ERSOY E., FIRAT H., AKAYDIN S., OZKAN Y., DURUSU M., DARILMAZ YUCE G., et al.
Tuberkuloz ve Toraks , cilt.62, sa.3, ss.207-214, 2014 (Scopus)

21. Relation of Kynurenine/Tryptophan with Immune and Inflammatory Markers in Coronary Artery Disease

Özkan Y., Şüküroğlu M. K., Tulmac M., Kısa Ü., Simsek B.
CLINICAL LABORATORY , cilt.60, sa.3, ss.391-396, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

22. Novel 1,3-diarylpyrazole acrylamides: synthesis, antiplatelet activity screening, and in silico evaluation studies

Baytaş S., Inceler N., Özkan Y., Unlu S., Sahin M. F.
MEDICINAL CHEMISTRY RESEARCH , cilt.22, sa.12, ss.5922-5933, 2013 (SCI-Expanded) identifier identifier

23. Retinal Ganglion Cell Protection Via Topical and Systemic Alpha-Tocopherol Administration in Optic Nerve Crush Model of Rat

Aktaş Z., Özmen M. C., Uyar Göçün F. P., Değim Z., Özkan Y., Önol M.
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , cilt.43, sa.3, ss.161-166, 2013 (ESCI) identifier identifier

24. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation

Levent S., ÇALIŞKAN B., Ciftci M., ÖZKAN Y., Yenicesu I., ÜNVER H., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.64, ss.42-53, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

25. Serum homocysteine levels and sildenafil 50 mg response in young-adult male patients without vascular risk factors

Basar M. M., ÖZKAN Y., KISA Ü., Simsek B.
INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS , cilt.50, sa.3, ss.215-220, 2013 (SCI-Expanded) identifier identifier identifier

26. The multidisciplinary approach to biochemistry laboratory education

Erkoc F., Sepici Dinçel A., Kayrin L., Özkan Y., Eksioglu S., Yüksel M., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.38, sa.4, ss.506-512, 2013 (SCI-Expanded, Scopus, TRDizin) identifier identifier

27. Increased kynurenine tryptophan and neopterin levels in hemodialysis.

Hacışevki A., Baba B., Sezer S., Özkan Y.
Oxidation Communications , cilt.36, sa.1, ss.246-253, 2013 (SCI-Expanded)

28. Variability of total thiol compounds, oxidative and nitrosative stress in uncomplicated pregnant women and nonpregnant women

Özkan Y., Yardim-Akaydin S., Erdem O. A., Simsek B.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS , cilt.285, sa.5, ss.1319-1324, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

29. Synthesis, anti-inflammatory, antiplatelet and in silico evaluations of (E)-3-(3-(2,3-dihydro-3-methyl-2-oxo-3H-benzoxazole-6-yl)-1-phenyl-1H-pyrazole-4-yl)acrylamides

BAYTAŞ S., Dural N. N. T., ÖZKAN Y., Simsek H. B., Gursel T., Unlu S.
TURKISH JOURNAL OF CHEMISTRY , cilt.36, sa.3, ss.367-382, 2012 (SCI-Expanded) identifier identifier

30. Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients

Özkan Y., Mete G., Sepici Dinçel A., Sepici V., Simsek B.
CLINICAL RHEUMATOLOGY , cilt.31, sa.1, ss.29-34, 2012 (SCI-Expanded) identifier identifier identifier

31. Increased tryptophan degradation in patients with bronchus carcinoma

Engin A. B., ÖZKAN Y., Fuchs D., Yardim-Akaydin S.
EUROPEAN JOURNAL OF CANCER CARE , cilt.19, sa.6, ss.803-808, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

32. OXIDATIVE STATUS AND SERUM HOMOCYSTEINE LEVELS WITH CORONARY ARTERY STENOSIS

GÖNENÇ A., Irmak S., ÖZKAN Y., Sahingeri M., Korkmaz M. E.
IUBMB LIFE , cilt.61, sa.3, ss.328, 2009 (SCI-Expanded) identifier

33. ROLE OF GLUCOCORTICOIDS DURING SEVOFLURANE ANAESTHESIA IN TOURNIQUET-INDUCED ISCHEMIA-REPERFUSION INJURY

Sepici-Dincel A., Ozkan Y., Izdes S., Gozdemir M., Kanbak O.
OXIDATION COMMUNICATIONS , cilt.32, sa.1, ss.226-235, 2009 (SCI-Expanded) identifier identifier

34. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)

Özkan Y., Firat H., Simsek B., Torun M., Yardim-Akaydin S.
SLEEP AND BREATHING , cilt.12, sa.2, ss.149-154, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

35. The effects of raloxifene and tibolone on homocysteine and vascular histopathological changes

Bayram M., Ozer G., Kalender H., Kabakci N., Kisa U., ÖZKAN Y.
CLINICAL AND EXPERIMENTAL MEDICINE , cilt.7, sa.4, ss.149-153, 2007 (SCI-Expanded) identifier identifier identifier

36. The effect of general and regional anaesthesia on ischaemia-reperfusion injury

Izdes S., Sepici-Dincel A., Gozdemir M., ÖZKAN Y., Kanbak O.
ANAESTHESIA AND INTENSIVE CARE , cilt.35, sa.3, ss.451-452, 2007 (SCI-Expanded) identifier identifier identifier

37. Usefulness of homocysteine as a cancer marker: Total thiol compounds and folate levels in untreated lung cancer patients

Özkan Y., Yardim-Akaydin S., Firat H., Caliskan-Can E., Ardic S., Simsek B.
ANTICANCER RESEARCH , cilt.27, sa.2, ss.1185-1189, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

38. Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease

ÖZKAN Y., Yardim-Akaydin S., Sepici A., Engin B., Sepici V., Simsek B.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE , sa.1, ss.73-77, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

39. Oxidative status in rheumatoid arthritis

ÖZKAN Y., Yardym-Akaydyn S., Sepici A., Keskin E., Sepici V., Simsek B.
CLINICAL RHEUMATOLOGY , cilt.26, sa.1, ss.64-68, 2007 (SCI-Expanded) identifier identifier identifier

40. The association between total antioxidant status and oxidative stress in Behcet's disease

Sepici-Dincel A., ÖZKAN Y., Yardim-Akaydin S., Kaymak-Karatas G. K., Onder M., Simsek B.
RHEUMATOLOGY INTERNATIONAL , cilt.26, sa.11, ss.1005-1009, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

41. Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation

ÖZKAN Y., Yardim-Akaydin S., Imren E., Torun M., Simsek B.
ACTA CARDIOLOGICA , cilt.61, sa.4, ss.432-439, 2006 (SCI-Expanded) identifier identifier identifier

42. Evaluation of allantoin levels as a new marker of oxidative stress in Behcet's disease

Yardim-Akaydin S., Sepici A., ÖZKAN Y., Simsek B., Sepici V.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.35, sa.1, ss.61-64, 2006 (SCI-Expanded) identifier identifier identifier

43. Prevalence of zinc deficiency and immune response in short-term hemodialysis

Bozalioglu S., ÖZKAN Y., Turan W., Simsek B.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY , cilt.18, sa.3, ss.243-249, 2005 (SCI-Expanded) identifier identifier identifier

44. Oxidation of uric acid in rheumatoid arthritis: Is allantoin a marker of oxidative stress?

Yardim-Akaydin S., Sepici A., ÖZKAN Y., Torun M., Simsek B., Sepici V.
FREE RADICAL RESEARCH , cilt.38, sa.6, ss.623-628, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

45. The role of plasma thiol compounds and antioxidant vitamins in patients with cardiovascular diseases

Yardim-Akaydin S., Ozkan Y., Ozkan E., Torun M., Simsek B.
CLINICA CHIMICA ACTA , cilt.338, sa.1-2, ss.99-105, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

46. An Evaluation of Serum Retinol and Carotene Levels and the Risk of Breast Cancer

HACIŞEVKİ A., ÖZKAN Y., GÖNENÇ A., Şimşek B., TORUN F. M.
Journal of Faculty of Pharmacy of Gazi University , cilt.20, sa.2, ss.87-94, 2003 (Hakemli Dergi) Sürdürülebilir Kalkınma

47. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease

Ozkan Y., Ozkan E., Simsek B.
INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.82, sa.3, ss.269-277, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

48. Ascorbic acid and alpha tocopherol levels in breast cancer patients

HACIŞEVKİ A., ÖZKAN Y., Şimşek B., TORUN F. M.
Journal of faculty of Pharmacy of Gazi University , cilt.19, sa.2, ss.113-119, 2002 (Hakemli Dergi) Sürdürülebilir Kalkınma

49. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients

Gonenc A., Ozkan Y., Torun M., Simsek B.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.26, sa.2, ss.141-144, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

50. Serum Vitamin E and Malondialdehyde levels in Cases with Head and Neck Cancer

ÖZKAN Y., Solak S., Şimşek B., TORUN F. M.
FABAD Journal of Pharmaceutical science , cilt.3, sa.23, ss.105-109, 1998 (Hakemli Dergi) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 35

1. Ariloksiaril Asetamit Yapısında Sirtuin İnhibitörü Olabilecek Bileşiklerin Tasarımı, Sentezi ve Biyolojik Aktivite Çalışmaları

KAYA S. G., ÖZKAN Y., BAKAR ATEŞ F., ÖZKAN E., EREN G.
VII. Ulusal Farmasötik Kimya Kongresi, İzmir, Türkiye, 26 - 28 Ekim 2024, (Özet Bildiri)

2. N-(5-(3-Methoxybenzyl)/(pyrimidin-2-yl-methyl))-1,3,4-oxadiazol-2-yl)-2-(arylthio)acetamide Derivatives as SIRT2 Inhibitors

AKSEL A. B., ÖZKAN Y., EREN G.
9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022), Nice, Fransa, 8 - 09 Eylül 2022, (Özet Bildiri)

3. In Silico Hit Optimization toward SIRT2 Inhibition: N-aryloxyaryl-2-(arylthio)acetamides

KAYA S. G., ÖZKAN Y., EREN G.
9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022), Nice, Fransa, 8 - 09 Eylül 2022, (Özet Bildiri)

4. Ariloksi Benzamit Yapısında Sirtuin İnhibitörü Olabilecek Bileşiklerin Tasarımı, Sentezi ve Biyolojik Aktivite Çalışmaları

YAĞCI S., GÖZELLE M., ÖZKAN Y., BAKAR ATEŞ F., EREN G.
VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Türkiye, 26 - 29 Ağustos 2022, (Özet Bildiri)

5. Yeni Nikotinamit Fosforiboziltransferaz (NAMPT) İnhibitör Adaylarının Sanal Tarama Yöntemi ile Keşfi ve Biyolojik Etkilerinin Belirlenmesi

ÖZGENCİL F., ÖZKAN Y., EREN G.
VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Türkiye, 26 - 29 Ağustos 2022, (Özet Bildiri)

6. IN SILICO HIT OPTIMIZATION TOWARD SIRT2 INHIBITION: N-ARYLOXYARYL-2-(ARYLTHIO)ACETAMIDES

KAYA S. G., ÖZKAN Y., EREN G.
EFMC-YMCS 9th Young Medicinal Chemists' Symposium, Nice, Fransa, 08 Eylül 2022, (Özet Bildiri)

7. N-(5-Arylmethyl-1,3,4-oxadiazole-2-yl)-2-(arylthio)acetamide as a New Scaffold for Developing Small-molecule SIRT Inhibitors

AKSEL A. B., ÖZKAN Y., EREN G.
GPSS-2021, 3rd International Gazi Pharma Symposium Series, Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

8. SIRT2 Inhibitory Activities of N-Aryloxyphenyl-2-(arylthio)acetamide Derivatives

KAYA S. G., ÖZKAN Y., EREN G.
GPSS-2021, 3rd International Gazi Pharma Symposium Series, Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

9. Discovery of 5-Benzyl-1,3,4-oxadiazole/thiadiazole-2-carboxamides as Potential Leads for Selective SIRT2 Inhibition

GÖZELLE M., ÖZKAN Y., EREN G.
GPSS-2021, 3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

10. Determination of tryptophan and kynurenine by LC-MS/MS by using amilodipine as internal standard

Eser B., ÖZKAN Y., SEPİCİ DİNÇEL A.
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019, Antalya, Türkiye, 27 - 31 Ekim 2019, cilt.44, ss.69, (Özet Bildiri)

11. Virtual Screening to Discover Drug Candidates Targeting Platelet Receptors

OLĞAÇ S., OLĞAÇ A., YENİCESU İ., ÖZKAN Y.
Asian Federation of Medicinal Chemistry (AFMC) 12th International Symposium, İstanbul, Türkiye, 8 - 11 Eylül 2019, (Özet Bildiri)

12. Antiplatelet aggregation of the secondary metabolites isolated from the aerial parts of Chrysophthalmum montanum (DC.) Boiss.

AYAZ F., ÖZKAN Y., OLĞAÇ S., GÖREN N., ÇALIŞ İ., Choudhary M. I., et al.
2nd International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2019), 28 - 29 Haziran 2019, (Özet Bildiri)

13. Virtual Screening for Small Molecule Inhibitors of Glycoprotein VI (GPVI)

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.
4th European Platelet Network (EUPLAN), 19 - 21 Eylül 2018, (Özet Bildiri)

14. ANTIPLATELET ACTIVITY OF LIGNANS FROM TAXUS BACCATA

KÜÇÜKBOYACI N., ÖZKAN Y., OLĞAÇ S., ŞENER B.
ISOPS 12, 26 - 29 Haziran 2018, (Özet Bildiri)

15. ANTIPLATELET ACTIVITY OF ISOLATED FLAVONOLS FROM SALSOLA GRANDIS AERIAL PARTS

KÜÇÜKBOYACI N., ÇALIŞ İ., ÖZKAN Y., OLĞAÇ S.
ISOPS 12th, 26 - 29 Haziran 2018, (Özet Bildiri)

16. In Vitro Antiplatelet Studies on Virtually Discovered GPVI Drug Candidates

OLĞAÇ S., Olgaç A., ÖZKAN Y.
12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2018, (Özet Bildiri)

17. Investigation of Serum Uric Acid and Allantoin Levels in Patients With Obstructive Sleep Apnea Hypopnea Syndrome

AKAYDIN S., SALİHOĞLU E., FIRAT H., ARDIÇ S., ÖZKAN Y., TORUN F. M., et al.
II. in vitro Diagnostic Biomarkers Symposium, 10 - 12 Mayıs 2017, cilt.42, ss.67, (Özet Bildiri)

18. Investigation of Novel Platelet Receptor GPVI Inhibitor Candidates

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.
2nd International Gazi Pharma Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

19. Uyku apne hipopne sendromlu hastalarda serum ürik asit ve allantoin düzeylerinin incelenmesi

AKAYDIN S., SALİHOĞLU E., Fırat H., ARDIÇ S., ÖZKAN Y., TORUN F. M., et al.
II. Türkiye in vitro diyagnostik sempozyumu Biyobelirteçler, Türkiye, 10 - 12 Mayıs 2017, (Özet Bildiri)

20. Neopterin:maligmitelerde prognostik bir belirteç

HACIŞEVKİ A., Baba B., Aslan S., ÖZKAN Y.
TBD Biyokimya Günleri, Türkiye, 2 - 05 Kasım 2016, cilt.40, (Özet Bildiri)

21. Neopterin: A Prognostic marker in human malignancies

HACIŞEVKİ A., BABA B., ASLAN S., ÖZKAN Y.
TBD, Biyokimya Günleri, Türkiye, 2 - 05 Kasım 2016

22. Structure Based Virtual Screening to Discover Platelet GPVI Inhibitors

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.
Third European Platelet Network (EUPLAN) Conference 2016, Bad Homburg vor der Höhe, Almanya, 21 - 23 Eylül 2016, (Özet Bildiri)

23. Screening FDA Approved Drugs to Discover Potent GPVI Inhibitors

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.
XXIV National Meeting in Medicinal Chemistry, Perugia, İtalya, 11 - 14 Eylül 2016, (Özet Bildiri)

24. Antiplatelet Etkide Yeni Hedef Sinyal Yolakları

ÖZKAN Y.
TBD Sivas Biyokimya Günleri, Türkiye, 2 - 05 Kasım 2016, cilt.41, (Tam Metin Bildiri)

25. Biyokimya laboratuvar eğitiminde inovasyon çalışmalar

YÜKSEL M., SEPİCİ DİNÇEL A., ÖZKAN Y., KAYRIN L.
27. Ulusal Biyokimya Kongresi, 3 - 06 Kasım 2015, cilt.40, (Özet Bildiri)

26. THE EFFECTS OF INFLIXIMAB AND 3 AMINOBENZAMIDE ONINDOLAMINE 2 3 DIOXYGENASE IDO ENZYMEIN TNBS INDUCED COLITIS MODEL

Bostancı Eker N., Sepici Dinçel A., Şüküroğlu M. K., Menekşe E., Dolapçı M., Cengiz Ö., et al.
INTERNATIONAL GAZI PHARMA SYMPOSIUM, Antalya, Türkiye, 12 - 15 Kasım 2015, ss.137, (Özet Bildiri) Creative Commons License

27. DESIGN SYNTHESIS AND EVALUATION OF NOVEL 1 3 DIARYLPYRAZOLES AS DUAL COX TXS INHIBITORS

BAYTAŞ S., inceler n., TURAN DURAL N. N., ÖZKAN Y.
GPSS2015, 12 - 15 Kasım 2015

28. Biyokimya Laboratuvar Eğitiminde İnovasyonÇalışmaları

KAYRIN L., ÖZKAN Y., SEPİCİ DİNÇEL A., YÜKSEL M.
XXVII. UlusalBiyokimya Kongresi, Türkiye, 3 - 06 Kasım 2015

29. Indolamine 2 3 dioxygenase related metabolic effects of 3 aminobenzamide and infliximab in lung tissue of experimental colitis model

ŞAHİN D., SEPİCİ DİNÇEL A., AKCA G., ÖZKAN Y., MENEKŞE E., DOLAPÇI M.
40th FEBS Congress, 4 - 09 Temmuz 2015, cilt.282, ss.279

30. Homocysteine Theory Past and Future Perspective

ÖZKAN Y.
CERES Spring 2015 Brown Bag Series, 09 Nisan 2015

31. Compounds Having Antiplatelet Activity: 3(2H) pyridazinone

ŞÜKÜROĞLU M. K., ÖZKAN Y.
European Platelet Network 2nd EUPLAN Conference, Le Bischenberg, Fransa, 24 Eylül 2014, (Özet Bildiri)

32. Multidisiplinary biochemistry laboratory education; student centered real learning process

SEPİCİ DİNÇEL A., Ozkan Y., Selvi M., Erkoc F.
FEBS EMBO 2014 Conference, Paris, Fransa, 30 Ağustos - 04 Eylül 2014, cilt.281, ss.428, (Özet Bildiri) identifier

33. Metastatik ve Non-metastatik meme kanserli hastalarda kinürenin/triptofan oranı

Arslan M. Ö., Özkan Y., Özaslan C., Yalçıntaş Arslan Ü.
XXV. Ulusal Biyokimya Kongresi, İzmir, Türkiye, 3 - 06 Eylül 2013, cilt.38, ss.249-0, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

34. Koroner Aterosklerozda Homosistein Tiyolaktonaz ve LDL Oksidasyonu

Altınay A., Tulmaç M., OLĞAÇ S., KISA Ü., Şimşek B., ÖZKAN Y.
XXV. Ulusal Biyokimya Kongresi, Türkiye, 3 - 06 Eylül 2013, (Özet Bildiri)

35. Evaluation of allontoin levels as a new marker of oxidative stress in Behcet's Disease

Akaydin S., Sepici A., Ozkan Y., Sepici V., Simsek B.
57th Annual Meeting of the American-Association-for-Clinical-Chemistry, Florida, Amerika Birleşik Devletleri, 24 - 28 Temmuz 2005, cilt.51, (Özet Bildiri) identifier
Kitaplar 5

1. Reseptörler: Yapı ve İşlevi

ŞÜKÜROĞLU M. K., ÖZKAN Y.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitapevleri, Ankara, ss.44-60, 2021

2. RESEPTÖRLER: YAPI VE İŞLEVİ

ŞÜKÜROĞLU M. K., ÖZKAN Y.
MEDİSİNAL KİMYA GİRİŞ, PROF. DR. ÖZTEKİN ALGÜL, Editör, NOBEL TIP YAYINEVİ, Ankara, ss.44-60, 2021

3. Pürin ve Pirimidin Nükleotitlerinin Metabolizması

ÖZKAN Y.
Harper’ın Resimli Biyokimyası, Doğan Yücel, Editör, Güneş Tıp Kitapevi, Ankara, ss.327-337, 2019

4. Nükleotitler

ÖZKAN Y.
Harper’ın Resimli Biyokimyası, Doğan Yücel, Editör, Güneş Tıp Kitapevi, Ankara, ss.319-326, 2019

5. Nükleik asit Yapı ve Fonksiyonu

ÖZKAN Y.
Harper’ın Resimli Biyokimyası, Doğan Yücel, Editör, Güneş Tıp Kitapevi, Ankara, ss.338-349, 2019
Metrikler

Yayın

93

Yayın (WoS)

45

Yayın (Scopus)

45

Atıf (WoS)

909

H-İndeks (WoS)

16

Atıf (Scopus)

998

H-İndeks (Scopus)

16

Atıf (Scholar)

1011

H-İndeks (Scholar)

12

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

4

Toplam Atıf Sayısı

914

Proje

34

Tez Danışmanlığı

6

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları